Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?

Editorial

D S Knopman. Neurology. 1998 May.

. 1998 May;50(5):1203-5.

doi: 10.1212/wnl.50.5.1203.

No abstract available

Comment in

Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
Sandson TA. Sandson TA. Neurology. 1999 Feb;52(3):675-6. doi: 10.1212/wnl.52.3.673-b. Neurology. 1999. PMID: 10025821 No abstract available.

Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.
Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B. Cummings JL, et al. Neurology. 1998 May;50(5):1214-21. doi: 10.1212/wnl.50.5.1214. Neurology. 1998. PMID: 9595966 Clinical Trial.
Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B. Morris JC, et al. Neurology. 1998 May;50(5):1222-30. doi: 10.1212/wnl.50.5.1222. Neurology. 1998. PMID: 9595967 Clinical Trial.